Brachial Plexus Block Completed Phase 3 Trials for Ropivacaine (DB00296)

IndicationStatusPhase
DBCOND0034625 (Brachial Plexus Block)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02787018Dexamethasone Compared With Dexmedetomidine as an Adjuvant to Ropivacaine for Supraclavicular Brachial Plexus BlockSupportive Care